Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

The use of the VerifyNow system to monitor antiplatelet therapy: a review of the current evidence.

van Werkum JW, Harmsze AM, Elsenberg EH, Bouman HJ, ten Berg JM, Hackeng CM.

Platelets. 2008 Nov;19(7):479-88. doi: 10.1080/09537100802317918. Review.

PMID:
18979359
2.

Benefits and limitations of current antiplatelet therapies.

Nappi J.

Am J Health Syst Pharm. 2008 Jul 1;65(13 Suppl 5):S5-10; quiz S16-8. doi: 10.2146/ajhp080156.

PMID:
18574022
3.

Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up.

Marcucci R, Gori AM, Paniccia R, Giusti B, Valente S, Giglioli C, Buonamici P, Antoniucci D, Abbate R, Gensini GF.

Circulation. 2009 Jan 20;119(2):237-42. doi: 10.1161/CIRCULATIONAHA.108.812636. Epub 2008 Dec 31.

4.

Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists.

Angiolillo DJ, Suryadevara S, Capranzano P, Zenni MZ, Guzman LA, Bass TA.

Catheter Cardiovasc Interv. 2009 Jan 1;73(1):1-14. doi: 10.1002/ccd.21782. Review.

PMID:
19089929
5.

Monitoring of the antiplatelet drugs effect in patients with coronary artery disease: what is the real clinical impact?

Christiaens L, Macchi L.

Curr Vasc Pharmacol. 2007 Oct;5(4):293-301. Review.

PMID:
17979795
6.

Current options in platelet function testing.

Michelson AD, Frelinger AL 3rd, Furman MI.

Am J Cardiol. 2006 Nov 20;98(10A):4N-10N. Epub 2006 Sep 29. Review.

PMID:
17097417
7.

Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives.

Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Alfonso F, Macaya C, Bass TA, Costa MA.

J Am Coll Cardiol. 2007 Apr 10;49(14):1505-16. Epub 2007 Mar 26. Review.

8.

Platelet function tests and resistance to antiplatelet therapy.

Stegnar M.

Srp Arh Celok Lek. 2010 Jan;138 Suppl 1:59-63. Review.

9.

Monitoring platelet function to reduce the risk of ischemic and bleeding complications.

Price MJ.

Am J Cardiol. 2009 Feb 2;103(3 Suppl):35A-39A. doi: 10.1016/j.amjcard.2008.11.022. Review.

PMID:
19166711
10.

Resistance to antiplatelet drugs: current status and future research.

Tantry US, Bliden KP, Gurbel PA.

Expert Opin Pharmacother. 2005 Oct;6(12):2027-45. Review.

PMID:
16197357
11.

Dual antiplatelet therapy monitoring for neurointerventional procedures using a point-of-care platelet function test: a single-center experience.

Lee DH, Arat A, Morsi H, Shaltoni H, Harris JR, Mawad ME.

AJNR Am J Neuroradiol. 2008 Aug;29(7):1389-94. doi: 10.3174/ajnr.A1070. Epub 2008 May 15.

12.

The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.

Toth PP.

Postgrad Med. 2009 Jan;121(1):59-72. doi: 10.3810/pgm.2009.01.1955. Review.

PMID:
19179814
14.

Monitoring of antiplatelet therapy. Current limitations, challenges, and perspectives.

Seidel H, Rahman MM, Scharf RE.

Hamostaseologie. 2011 Feb;31(1):41-51. doi: 10.5482/ha-1146. Review.

PMID:
21311822
15.

Risk stratification after coronary artery bypass surgery by a point-of-care test of platelet function.

Bevilacqua S, Alkodami AA, Volpi E, Cerillo AG, Berti S, Glauber M, Gianetti J.

Ann Thorac Surg. 2009 Feb;87(2):496-502. doi: 10.1016/j.athoracsur.2008.05.038.

PMID:
19161767
16.

Variability in responsiveness to oral antiplatelet therapy.

Angiolillo DJ.

Am J Cardiol. 2009 Feb 2;103(3 Suppl):27A-34A. doi: 10.1016/j.amjcard.2008.11.020. Review.

PMID:
19166710
17.

Comparison of different methods to evaluate the effect of aspirin on platelet function in high-risk patients with ischemic heart disease receiving dual antiplatelet treatment.

Paniccia R, Antonucci E, Gori AM, Marcucci R, Poli S, Romano E, Valente S, Giglioli C, Fedi S, Gensini GF, Abbate R, Prisco D.

Am J Clin Pathol. 2007 Jul;128(1):143-9.

PMID:
17580282
18.

Variability in platelet response to the antiplatelet agents aspirin and clopidogrel: mechanisms, measurement, and clinical relevance.

Jennings LK.

Crit Pathw Cardiol. 2009 Mar;8(1):20-8. doi: 10.1097/HPC.0b013e318194e45e. Review.

PMID:
19258834
19.

Platelet function monitoring in patients with coronary artery disease.

Gurbel PA, Becker RC, Mann KG, Steinhubl SR, Michelson AD.

J Am Coll Cardiol. 2007 Nov 6;50(19):1822-34. Epub 2007 Oct 23. Review.

20.

Optimizing antiplatelet therapy following percutaneous coronary intervention: clinical pathways for platelet function testing.

Lassar TA, Simon DI, Croce K.

Rev Cardiovasc Med. 2011;12 Suppl 1:S23-33. Review.

PMID:
22080984

Supplemental Content

Support Center